SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $62 | -99.9% | 3,688 | -10.0% | 0.00% | 0.0% |
| Q3 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $70,000 | +2233.3% | 4,098 | +1889.3% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 206 | -17.6% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 250 | -7.1% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 269 | +31.9% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 204 | +30.8% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 156 | -1.9% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 159 | -68.2% | 0.00% | – |
| Q3 2018 | $8,000 | +300.0% | 500 | +316.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 120 | +7.1% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 112 | +6.7% | 0.00% | – |
| Q3 2017 | $2,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |